Drug Marketing Restrictions Pending In Several State Legislatures
Executive Summary
Legislation is pending in several state legislatures that would require pharmaceutical sales representatives to register as lobbyists. Those include legislatures in Louisiana, Connecticut, New Hampshire and Colorado
You may also be interested in...
Attempts To Rein In Drug Reps Should Consider Physician Specialty, Setting
Guidelines directed at the interaction of sales representatives and physicians should be tailored to medical specialties and settings, according to an analysis of a physician survey published in the April 26 New England Journal of Medicine
Attempts To Rein In Drug Reps Should Consider Physician Specialty, Setting
Guidelines directed at the interaction of sales representatives and physicians should be tailored to medical specialties and settings, according to an analysis of a physician survey published in the April 26 New England Journal of Medicine
Pharma Access To Prescribing Data Could Decline Under New AMA Policy
The American Medical Association is instituting a data restriction program to address growing concern about the appropriate use of physician prescribing information